Bank of New York Mellon’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
246,586
+5,651
+2% +$24.9K ﹤0.01% 3345
2026
Q1
$870K Sell
240,935
-14,757
-6% -$51.1K ﹤0.01% 3290
2025
Q4
$872K Sell
255,692
-2,804
-1% -$13.6K ﹤0.01% 3320
2025
Q3
$1.76M Buy
258,496
+3,122
+1% +$25.8K ﹤0.01% 2871
2025
Q2
$3.48M Buy
255,374
+47,675
+23% +$450K ﹤0.01% 2471
2025
Q1
$1.13M Sell
207,699
-2,553
-1% -$14.5K ﹤0.01% 2995
2024
Q4
$1.04M Buy
210,252
+1,511
+0.7% +$7.92K ﹤0.01% 3138
2024
Q3
$1.09M Sell
208,741
-25,842
-11% -$149K ﹤0.01% 3091
2024
Q2
$1.61M Buy
234,583
+91,183
+64% +$834K ﹤0.01% 2917
2024
Q1
$1.47M Sell
143,400
-20,059
-12% -$148K ﹤0.01% 2938
2023
Q4
$1.36M Buy
163,459
+131,847
+417% +$948K ﹤0.01% 3027
2023
Q3
$198K Sell
31,612
-681
-2% -$2.95K ﹤0.01% 3961
2023
Q2
$140K Sell
32,293
-182
-0.6% -$404 ﹤0.01% 4046
2023
Q1
$55.2K Hold
32,475
﹤0.01% 4176
2022
Q4
$63K Sell
32,475
-202
-0.6% -$453 ﹤0.01% 4199
2022
Q3
$64K Buy
+32,677
New +$77.9K ﹤0.01% 4283

Other funds holding LFMD

Bank of New York Mellon's LFMD Position: Q2 2026 in Review

Bank of New York Mellon increased its LifeMD (LFMD) stake by 2.3% in Q2 2026, buying an estimated $24.9K and bringing the position to 246,586 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3345.

Bank of New York Mellon first reported a position in LFMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.48M in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Bank of New York Mellon held 246,586 shares of LifeMD worth $1.02M as of Q2 2026.
  • Bank of New York Mellon bought 5,651 LifeMD shares in Q2 2026, an estimated $24.9K.
  • LifeMD made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3345 holding.
  • Bank of New York Mellon first reported a position in LifeMD in Q3 2022 and has held it in 16 quarters since.
  • Bank of New York Mellon's LifeMD position peaked at $3.48M in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.